Compounds > n-methyl-3,4-methylenedioxyamphetamine

n-methyl-3,4-methylenedioxyamphetamine and norfluoxetine

n-methyl-3,4-methylenedioxyamphetamine has been researched along with norfluoxetine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clemens, KJ; Cornish, JL; Gurtman, CG; Hunt, GE; Li, KM; McGregor, IS; Thompson, MR1

Other Studies

1 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and norfluoxetine

ArticleYear
Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2004, Volume: 29, Issue:4

    Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Body Fluids; Body Temperature; Body Weight; Brain; Carrier Proteins; Chromatography, High Pressure Liquid; Depression; Drinking; Drug Interactions; Fluoxetine; Immobilization; Male; Membrane Glycoproteins; Membrane Transport Proteins; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Neurotransmitter Agents; Psychomotor Performance; Rats; Rats, Wistar; Reaction Time; Serotonin Plasma Membrane Transport Proteins; Swimming

2004